Douglas Van Nostrand, M.D.

Douglas Van Nostrand, M.D., Nuclear Medicine Physician, is Director of Nuclear Medicine of the Division of Medicine at Washington Hospital Center in Washington, DC. He is also Professor of Medicine at Georgetown University Hospital and Director of the Washington Hospital Center’s nuclear medicine residency program. Prior to joining the Hospital Center, Dr. Van Nostrand was director of nuclear medicine at Good Samaritan Hospital in Baltimore, Maryland, after serving in the United States Army as director of nuclear medicine at Walter Reed Army Medical Center and in the US Air Force as director of nuclear medicine at Malcolm Grow Medical Center in Washington, D.C. Dr. Van Nostrand completed his postgraduate training in internal medicine at Wilford Hall Medical Center in San Antonio, Texas, and his nuclear medicine training at the National Naval Medical Center in Bethesda, Maryland. He has an M.D. degree from Emory University School of Medicine and a B.S. from Duke University. He has held numerous leadership positions, has received numerous awards, and has authored or coauthored more than 100 abstracts, articles, and chapters. He also has edited and co-edited seven medical books for professionals and patients including the patients’ reference Thyroid Cancer: A Guide for Patients, and the medical textbook co-authored with Dr. Leonard Wartofsky, Thyroid Cancer: A Comprehensive Guide to Clinical Management.

R. Michael Tuttle, M.D. is an Endocrinologist at Memorial Sloan-Kettering Cancer Center, New York, New York. He also serves as Professor of Medicine at the Joan and Sanford I. Weill Medical College of Cornell University in New York, NY. He is an active clinician and researcher specializing in the management of advanced thyroid cancer. He travels extensively both within the US and abroad lecturing on the difficult management issues in thyroid cancer. His research projects in radiation- induced thyroid cancer have taken him from Kwajalein Atoll in the Marshall Islands to the Hanford Nuclear power-plant in Washington State to regions in Russia that were exposed to fallout from the Chernobyl accident. He serves on the American Thyroid Association committee that produced the current guidelines for the management of benign and malignant thyroid nodules. He also chaired the National Comprehensive Cancer Network Thyroid Cancer Panel, and served on the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug, and as a consultant.

Carole A. Spencer, Ph.D., F.A.C.B., is Professor of Medicine in the Keck School of Medicine at USC, where she also is a licensed medical technologist, and directs the USC Endocrine Laboratories. Dr. Spencer received a B.S. in Applied Biochemistry from Bath University of Technology in England, U.K., and a Ph.D. from the Department of Medicine at Glasgow University, Scotland, U.K. In 1977, she joined the University of Southern California in Los Angeles. The author or co-author of more than 80 original papers, chapters and monographs, Dr. Spencer has focused her research on the clinical and laboratory aspects of thyroid disease and treatment. She is a Past President of the American Thyroid Association.

Julie Ann Sosa, M.D., M.A., is an Endocrine and Oncologic Surgeon at the University of California, San Francisco.  Her previous position was at Duke University Medical Center in Durham, North Carolina. She is principal investigator or co-principal investigator of studies of new drug treatments for differentiated thyroid cancer (papillary/follicular), medullary thyroid cancer, and anaplastic thyroid cancer. Following undergraduate education at Princeton University, she received a master’s degree in Human Sciences at the University of Oxford in the United Kingdom and her medical degree from Johns Hopkins University School of Medicine, Baltimore, Maryland. She received postgraduate training at Johns Hopkins Hospital in Baltimore, Maryland, as well as John Radcliffe and Churchill Hospitals, Oxford, England. She is a frequent invited lecturer and course leader/instructor for professional audiences.

Monica C. Skarulis, M.D. is an Endocrinologist in the National Institutes of Diabetes, Digestive & Kidney Diseases (NIDDK) at the National Institutes of Health in Bethesda, Maryland. .  She is Section Chief, Clinical Endocrinology Section, Diabetes, Endocrinology and Obesity Branch.  Dr. Skarulis has received three commendations from the U.S. Public Health Service. She has been honored with the NIH Director’s Award of Merit and has been recognized for her teaching by NIH fellows and the Uniformed Services University of the Health Sciences.  Dr. Skarulis earned her medical degree from New York Medical College. She completed an internship and residency in internal medicine at Cornell University Medical College and an endocrine fellowship at NIH.

Peter A. Singer, M.D., Endocrinologist, graduated from the Medical School of the University of California at San Francisco, and did his internship at Los Angeles County General Hospital (now LAC-USC Medical Center). He then served two years in the military, including a tour of duty in Vietnam. Dr. Singer then returned to LAC-USC for a medical residency and an NIH-funded endocrine fellowship. He was for many years a faculty member of the USC Division of Endocrinology at USC. In 1991, Dr. Singer moved his practice to USC and, since then has been Professor and Chief of Clinical Endocrinology at the Keck School of Medicine, USC. In addition to a full-time clinical practice in endocrinology, he also teaches medical students, residents and endocrine fellows. In 2004, Dr. Singer was named the Outstanding Clinical Endocrinologist by the American Association of Clinical Endocrinologists. He is a Past President, of the American Thyroid Association.

Steven I. Sherman, M.D., Endocrinologist, is Chair of the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center, Houston, Texas, where he is also a Professor. He is also Adjunct Associate Professor of Medicine at Baylor College of Medicine. A Magna Cum Laude graduate of Harvard College, he received his M.D. from Johns Hopkins School of Medicine, followed by internship, residency, and fellowship at Johns Hopkins Hospital, Baltimore, Maryland, and 3 years as a Clinical Associate Physician, National Institutes of Health, Bethesda, Maryland. His research interests include novel therapies for thyroid carcinoma and recombinant human TSH. He is coauthor of the American Thyroid Association Guidelines on Differentiated Thyroid Cancer and a Board Member of the American Thyroid Association.

Manisha H. Shah, M.D., Oncologist, is Professor at the Ohio State University College of Medicine. Her clinical research interests include thyroid cancer, neuroendocrine cancers, and adrenal cancers. Her group focuses on discovering new targeted therapies and conducts phase II-III clinical trials, leading many national studies. The group also conducts pre- clinical studies to learn types of drugs and combination of drugs and apply that knowledge to design clinical trials. Dr. Shah is the author of numerous articles.

Martin Schlumberger, MD, is Professor of Oncology at the University Paris-Sud 11, France, and Chairman of the Department of Nuclear Medicine and Endocrine Oncology, Institut Gustave Roussy, Villejuif, France. He is involved in Nuclear Medicine and in the diagnosis, treatment and follow-up of endocrine tumors, with thyroid cancer and in particular refractory patients being his main field of interest

Pamela Schultz, R.N., Ph.D. is Professor of Nursing and Interim Director of the School of Nursing at New Mexico State University in Las Cruces, New Mexico. Her interests include Mental Health and Oncology Research Projects regarding Long-Term Cancer Survivorship and the quality of life of cancer survivors. Previously she was Program Director for Endocrinology in the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson Cancer Center in Houston, Texas, where she worked for more than 30 years. In addition to her nursing and doctoral degrees, she has a master’s degree in psychiatric mental health nursing and has facilitated cancer support groups for families and patients.